首页|定点突变优化信号肽对嵌合抗原受体T细胞功能的影响

定点突变优化信号肽对嵌合抗原受体T细胞功能的影响

扫码查看
信号肽(signal peptide,SP)参与调节嵌合抗原受体(chimeric antigen receptor,CAR)结构的分泌水平及跨膜易位过程,对嵌合抗原受体T细胞(chimeric antigen receptor T cell,CAR-T)行使功能至关重要,本研究通过定点突变技术优化 SP 序列,并研究其对 CD19-CAR-T 杀伤功能的影响.首先,利用基因合成和分子克隆技术,构建含野生型SP(SP-wtY)、2种突变型SP(SP-muK或SP-muR)的靶向CD19 的CAR载体;对构建成功的载体进行慢病毒包装,并使用慢病毒侵染T细胞,利用流式细胞术检测细胞的转染效率,钙黄绿素释放法检测对靶细胞的体外杀瘤能力,酶联免疫吸附(enzyme linked immunosorbent assay,ELISA)技术检测 2 种细胞因子[干扰素-γ(interferon-γ,IFN-γ)和干扰素-α(interferon-α,TNF-α)]的分泌水平.结果显示,构建了野生型和信号肽突变的重组慢病毒质粒,慢病毒转导T细胞后,携带 3 种信号肽(SP-wtY、SP-muK或SP-muR)的CD19-CAR转染效率分别为 33.9%、35.5%、36.8%.进一步杀伤实验显示,与SP-muK和SP-wtY细胞相比,SP-muR细胞的肿瘤杀伤效果显著提高,当效靶比为 10:1 时共培养 24 h后,SP-muR组CAR-T细胞的细胞因子IFN-γ和TNF-α分泌水平显著高于SP-muK和SP-wtY组.本研究揭示信号肽N端正电荷数的增加可以提高CAR的表达效率和对CD19+靶细胞的杀伤作用,为CAR结构的优化改造和临床高效应用提供了科学依据.
Effect of signal peptide optimized by site-directed mutagenesis on the function of chimeric antigen receptor T cells
Signal peptides(SP)are involved in regulating the secretion level and transmembrane translocation of chimeric antigen receptors(CAR),which is crucial for CAR-T cells.This study aimed to optimize the SP sequence by site-directed mutagenesis and investigate its impact on the killing function of CD19-CAR-T.Firstly,CAR vectors targeting CD19 containing wild-type SP(SP-wtY)or two mutant SP(SP-muK or SP-muR)were constructed using gene synthesis and molecular cloning techniques.The successfully constructed vector was packaged with lentivirus,and T cells were infected.The transfection efficiency of T cells was detected by flow cytometry,while the killing effect on target cells was assessed using the calcein release method.The secretion levels of cytokines interferon-γ(IFN-γ)and interferon-α(TNF-α)were measured using enzyme linked immunosorbent assay(ELISA).The results showed that successful construction of recombinant lentivirus plasmids with wild type and signal peptide mutation.After the transferring the lentivirus into T cells,the transfection efficiency of CD19-CAR carrying three signal peptides(SP-wtY,SP-muK,or SP-muR)were 33.9%,35.5%,and 36.8%,respectively.Further killing assay showed that the tumor-killing effect of SP-muR cells was significantly higher than that of SP-muK and SP-wtY cells.When the ratio of effector to target was 10:1,the secretion levels of cytokines IFN-γ and TNF-α of CAR-T cells of the SP-muR group were significantly higher than those in SP-muK and SP-wtY groups.In summary,this study revealed that increasing the N-terminal positive charge of the signal peptide can improve the expression efficiency of CAR and promote the killing of CD19+target cells.These findings provide a scientific basis the optimization and clinical application of CAR structure.

point mutationsignal peptidechimeric antigen receptorCD19-CAR-T cellskilling tumor in vitrocytokines

刘玉、李帆、戴蕙芸、周润龙、王梦怡、甘世豪、徐瑶

展开 >

武汉科技大学生命科学与健康学院 生物医学研究院,湖北 武汉 430081

武汉波睿达生物科技有限公司,湖北 武汉 430075

定点突变 信号肽 嵌合抗原受体 CD19-CAR-T细胞 体外杀瘤 细胞因子

湖北省科技厅支持企业创新发展项目武汉东湖高新区"揭榜挂帅"项目

2021BAB1262022KJB113

2024

生物工程学报
中国科学院微生物研究所 中国微生物学会

生物工程学报

CSTPCD北大核心
影响因子:0.641
ISSN:1000-3061
年,卷(期):2024.40(2)